We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$512M
Cap. Flow %
15.52%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.4M
2
XLRN
Acceleron Pharma
XLRN
+$7.85M
3
BHC icon
Bausch Health
BHC
+$7.4M
4
ALB icon
Albemarle
ALB
+$6.62M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.61M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10M
3
AMGN icon
Amgen
AMGN
+$7.37M
4
CBRL icon
Cracker Barrel
CBRL
+$5.6M
5
COST icon
Costco
COST
+$5.44M

Sector Composition

Rank Sector Weight
1 Healthcare 3.28%
2 Communication Services 1.55%
3 Technology 0.91%
4 Consumer Discretionary 0.74%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APO icon
976
CALL
Apollo Global Management
APO
$69B
– –
-90,000
Closed -$5.6M
ARE icon
977
CALL
Alexandria Real Estate Equities
ARE
$9.37B
– –
-20,000
Closed -$3.64M
ARKG icon
978
ARK Genomic Revolution ETF
ARKG
$1.53B
– –
-12,000
Closed -$1.01M
ARKK icon
979
PUT
ARK Innovation ETF
ARKK
$5.59B
– –
-20,000
Closed -$2.62M
ASHR icon
980
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
– –
-17,400
Closed -$705K
ASMB icon
981
Assembly Biosciences
ASMB
$498M
– –
-833
Closed -$39K
ASND icon
982
CALL
Ascendis Pharma A/S
ASND
$16.5B
– –
-5,000
Closed -$658K
ASPN icon
983
CALL
Aspen Aerogels
ASPN
$339M
– –
-10,900
Closed -$326K
ASPN icon
984
Aspen Aerogels
ASPN
$339M
– –
-6,000
Closed -$180K
ASPN icon
985
PUT
Aspen Aerogels
ASPN
$339M
– –
-25,000
Closed -$748K
ASTS icon
986
CALL
AST SpaceMobile
ASTS
$15.8B
– –
-100,000
Closed -$1.29M
ATI icon
987
CALL
ATI
ATI
$24.3B
– –
-15,000
Closed -$313K
FRMM
988
CALL
Forum Markets
FRMM
$69.9M
– –
-17
Closed -$650K
ATOS icon
989
Atossa Therapeutics
ATOS
$23M
– –
-167
Closed -$9.71K
AU icon
990
CALL
AngloGold Ashanti
AU
$39.4B
– –
-110,000
Closed -$2.04M
AXON
991
CALL
Axon Enterprise
AXON
$42.8B
– –
-10,000
Closed -$1.77M
AZTA icon
992
CALL
Azenta
AZTA
$1.3B
– –
-21,700
Closed -$2.07M
AZUL
993
CALL
DELISTED
Azul
AZUL
– –
-30,000
Closed -$792K
BA icon
994
PUT
Boeing
BA
$169B
– –
-15,000
Closed -$3.59M
BABA icon
995
PUT
Alibaba
BABA
$276B
– –
-5,000
Closed -$1.13M
BALY icon
996
Bally's
BALY
$708M
– –
-4,000
Closed -$195K
BBIO icon
997
CALL
BridgeBio Pharma
BBIO
$16.4B
– –
-10,000
Closed -$610K
BBWI icon
998
CALL
Bath & Body Works
BBWI
$3.97B
– –
-70,509
Closed -$3.45M
BBY icon
999
Best Buy
BBY
$19B
– –
-1,100
Closed -$126K
BCE icon
1000
BCE
BCE
$20.8B
– –
-20,000
Closed -$1.01M
38 39
40
41 42

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.